Rescue of cardiac function in obese type-2 diabetic mice by transfer of a human longevity gene

被引：0
|
作者：
Avolio, E. [1 ]
Thomas, A. [1 ]
Dang, Z. [1 ]
Faulkner, A. [1 ]
Gu, Y. [1 ]
Beltrami, A. P. [2 ]
Carrizzo, A. [3 ]
Maciag, A. [4 ]
Ciaglia, E. [5 ]
Ferrario, A. [4 ]
Damato, A. [3 ]
Spinetti, G. [4 ]
Vecchione, C. [3 ]
Puca, A. A. [5 ]
Madeddu, P. [1 ]
机构：
[1] Univ Bristol, Bristol Med Sch, Bristol, Avon, England
[2] Univ Udine, Dept Pathol, Udine, Italy
[3] Irccs INM Neuromed, Dept Vasc Physiopathol, Pozzilli, Italy
[4] IRCCS MultiMed, Cardiovasc Dept, Milan, Italy
[5] Univ Salerno, Dept Med, Salerno, Italy
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3653 / 3653
页数：1
相关论文
共 50 条
  • [1] Transfer of a human gene variant associated with exceptional longevity improves cardiac function in obese type 2 diabetic mice through induction of the SDF-1/CXCR4 signalling pathway
    Dang, Zexu
    Avolio, Elisa
    Thomas, Anita C.
    Faulkner, Ashton
    Beltrami, Antonio P.
    Cervellin, Celeste
    Carrizzo, Albino
    Maciag, Anna
    Gu, Yue
    Ciaglia, Elena
    Finato, Nicoletta
    Damato, Antonio
    Spinetti, Gaia
    Alenzi, Aishah
    Paisey, Stephen J.
    Vecchione, Carmine
    Puca, Annibale A.
    Madeddu, Paolo
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (09) : 1568 - 1581
  • [2] Irbesartan improves renal and cardiac complications of obese and type 2 diabetic mice
    Liu, Lei
    Dong, Yi Fei
    Kataoka, Keiichiro
    Nako, Hisato
    Nakamura, Taishi
    Yamamoto, Eiichiro
    Fukuda, Masaya
    Mitsuyama, Shokei
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 87P - 87P
  • [3] Role of Osteopontin in Corneal Surface Barrier Function in Type-2 Diabetic Mice
    Datta, Ananya
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [4] Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer
    Metcalfe, BL
    Huentelman, MJ
    Parilak, LD
    Taylor, DG
    Katovich, MJ
    Knot, HJ
    Sumners, C
    Raizada, MK
    HYPERTENSION, 2004, 43 (06) : 1233 - 1238
  • [5] FLUOXETINE IN THE TREATMENT OF OBESE TYPE-2 DIABETIC-PATIENTS
    OKANE, M
    WILES, PG
    WALES, JK
    DIABETIC MEDICINE, 1994, 11 (01) : 105 - 110
  • [6] Cardiac myocytes from type-2 diabetic mice shows altered Ca2+handling
    Pereira, L
    Richard, S
    Gomez, AM
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 183A - 183A
  • [7] Myenteric plexus of obese diabetic mice (an animal model of human type 2 diabetes)
    Spångéus, A
    El-Salhy, M
    HISTOLOGY AND HISTOPATHOLOGY, 2001, 16 (01) : 159 - 165
  • [8] Cholesterol-lowering gene therapy prevents HFpEF in obese type 2 diabetic mice
    Aboumsallem, J. P.
    Muthuramu, I.
    Mishra, M.
    De Geest, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 165 - 165
  • [9] CHOLESTERYL ESTER TRANSFER IN TYPE-2 DIABETIC-PATIENTS
    MURAKAMI, T
    MIZUSHIMA, Y
    GIANFRANCESCHI, G
    SIRTORI, CR
    FRANCESCHINI, G
    DIABETOLOGIA, 1995, 38 : A249 - A249
  • [10] Increase of cardiac M2-muscarinic receptor gene expression in type-1 but not in type-2 diabetic rats
    Lee, Liang-Ming
    Chang, Cheng Kuei
    Cheng, Kai-Chun
    Kou, Dai-Huang
    Liu, I-Min
    Cheng, Juei-Tang
    NEUROSCIENCE LETTERS, 2008, 441 (02) : 201 - 204
12345